MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,879,000 | -30.0% | 117,132 | +1.1% | 0.00% | -33.3% |
Q2 2023 | $2,685,000 | -14.4% | 115,823 | -14.2% | 0.00% | -25.0% |
Q1 2023 | $3,136,000 | +60.1% | 135,000 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $1,959,000 | -24.9% | 135,000 | -0.6% | 0.00% | -33.3% |
Q3 2022 | $2,607,000 | +5.0% | 135,784 | -0.6% | 0.00% | 0.0% |
Q2 2022 | $2,482,000 | -27.9% | 136,620 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $3,443,000 | -8.7% | 136,620 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $3,771,000 | -14.5% | 136,620 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $4,411,000 | +5.6% | 136,620 | 0.0% | 0.00% | +33.3% |
Q2 2021 | $4,178,000 | -0.6% | 136,620 | -1.0% | 0.00% | -50.0% |
Q1 2021 | $4,203,000 | +52.8% | 138,023 | -0.8% | 0.01% | +50.0% |
Q4 2020 | $2,751,000 | +51.7% | 139,084 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $1,813,000 | +15.0% | 139,084 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,577,000 | -20.3% | 139,084 | +0.6% | 0.00% | -25.0% |
Q1 2020 | $1,979,000 | -47.5% | 138,300 | 0.0% | 0.00% | -20.0% |
Q4 2019 | $3,766,000 | -7.2% | 138,300 | -2.4% | 0.01% | -28.6% |
Q3 2019 | $4,057,000 | -66.9% | 141,700 | -67.9% | 0.01% | 0.0% |
Q2 2019 | $12,249,000 | +173.3% | 441,000 | +226.7% | 0.01% | -12.5% |
Q1 2019 | $4,482,000 | +14.2% | 135,000 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $3,924,000 | -36.9% | 135,000 | -0.1% | 0.01% | -20.0% |
Q3 2018 | $6,219,000 | +19.6% | 135,200 | -2.8% | 0.01% | +11.1% |
Q2 2018 | $5,198,000 | +20.4% | 139,100 | -4.8% | 0.01% | +12.5% |
Q1 2018 | $4,317,000 | -13.6% | 146,100 | +0.4% | 0.01% | -11.1% |
Q4 2017 | $4,998,000 | +2.3% | 145,500 | +7.8% | 0.01% | 0.0% |
Q3 2017 | $4,884,000 | +40.0% | 135,000 | 0.0% | 0.01% | +50.0% |
Q2 2017 | $3,488,000 | +34.6% | 135,000 | 0.0% | 0.01% | +20.0% |
Q1 2017 | $2,592,000 | +15.2% | 135,000 | 0.0% | 0.01% | +25.0% |
Q4 2016 | $2,250,000 | +68.2% | 135,000 | +107.7% | 0.00% | +33.3% |
Q3 2016 | $1,338,000 | -66.4% | 65,000 | -50.0% | 0.00% | -25.0% |
Q2 2016 | $3,978,000 | +63.5% | 130,000 | +100.0% | 0.00% | -20.0% |
Q1 2016 | $2,433,000 | -68.1% | 65,000 | -63.2% | 0.01% | -68.8% |
Q4 2015 | $7,618,000 | +10.8% | 176,500 | -3.8% | 0.02% | +6.7% |
Q3 2015 | $6,874,000 | +12.1% | 183,400 | +1.7% | 0.02% | +25.0% |
Q2 2015 | $6,132,000 | -4.0% | 180,400 | 0.0% | 0.01% | -7.7% |
Q1 2015 | $6,386,000 | -11.7% | 180,400 | -15.1% | 0.01% | -13.3% |
Q4 2014 | $7,234,000 | -10.4% | 212,400 | +1.4% | 0.02% | -11.8% |
Q3 2014 | $8,077,000 | +0.1% | 209,400 | +1.0% | 0.02% | -5.6% |
Q2 2014 | $8,072,000 | +12.8% | 207,400 | -1.0% | 0.02% | +50.0% |
Q1 2014 | $7,159,000 | +65.3% | 209,400 | +1.5% | 0.01% | +50.0% |
Q4 2013 | $4,330,000 | +130.3% | 206,400 | +158.0% | 0.01% | +100.0% |
Q3 2013 | $1,880,000 | +598.9% | 80,000 | +700.0% | 0.00% | +300.0% |
Q2 2013 | $269,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |